Literature DB >> 3351149

Balloon dilation of critical pulmonary stenosis in the first week of life.

B Zeevi1, J F Keane, K E Fellows, J E Lock.   

Abstract

Although balloon dilation of valvular pulmonary stenosis is established in infants and children, the techniques for and results of balloon dilation in neonates with critical pulmonary stenosis remain largely unreported. Since January 1, 1985, six successive neonates with critical pulmonary stenosis (aged 1 to 6 days) underwent attempted balloon dilation. Each was cyanotic and three of the six were on prostaglandin E1 therapy and three required tracheal intubation and ventilation. All had suprasystemic right ventricular pressures (mean 122.8 +/- 6.8 mm Hg). After hemodynamic evaluation and right ventricular angiography, the valve was crossed in five patients, and was first dilated with a low profile, 5 or 6 mm diameter, 2 cm long balloon. At least one more balloon was used in each patient, the largest being 95 to 133% of the diameter of the pulmonary valve anulus. The anulus size was 6.8 +/- 1.1 mm and the largest balloon size used was 6 to 10 mm. Right ventricular pressure decreased to nearly systemic level or less in five of five patients (58.8 +/- 6.7 mm Hg). Pressure gradients, measured in four infants, were 7, 12, 16 and 35 mm Hg, respectively, but were unreliable indicators of obstruction because of a patent ductus arteriosus. The five patients were discharged 3 to 8 days after balloon dilation. All are currently symptom free 10.6 +/- 11.7 months later, and all but one are believed clinically to have mild obstruction. Complications included iliac vein occlusion (n = 1) and complete right bundle branch block (n = 1). Although follow-up has been brief, neonates with critical pulmonary stenosis can safely undergo balloon dilation, usually with good short-term results.

Entities:  

Mesh:

Year:  1988        PMID: 3351149     DOI: 10.1016/0735-1097(88)90217-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  9 in total

Review 1.  Interventional pediatric cardiology: state of the art and future perspective.

Authors:  W A Radtke
Journal:  Eur J Pediatr       Date:  1994-08       Impact factor: 3.183

2.  Dilatation with progressively larger balloons for severe stenosis of the pulmonary valve presenting in the late neonatal period and early infancy.

Authors:  S A Qureshi; E J Ladusans; R P Martin
Journal:  Br Heart J       Date:  1989-10

3.  Transient complete heart block following percutaneous balloon pulmonary valvuloplasty: treatment with systemic corticosteroids.

Authors:  C Steinberg; A R Levin; M A Engle
Journal:  Pediatr Cardiol       Date:  1992-07       Impact factor: 1.655

4.  Arterial duct angioplasty as an adjunct to dilatation of the valve for critical pulmonary stenosis.

Authors:  K P Walsh; S E Abrams; R Arnold
Journal:  Br Heart J       Date:  1993-03

5.  Immediate- and medium-term effects of balloon pulmonary valvuloplasty in infants with critical pulmonary stenoses during the first year of life: A prospective single center study.

Authors:  Manal Hassan Saad; Alaa Mahmoud Roushdy; Maiy Hamdy Elsayed
Journal:  J Saudi Heart Assoc       Date:  2010-08-05

6.  Surgical closed pulmonary valvotomy for critical pulmonary stenosis: implications for the balloon valvuloplasty era.

Authors:  A Smolinsky; R Arav; J Hegesh; A Lusky; D A Goor
Journal:  Thorax       Date:  1992-03       Impact factor: 9.139

7.  Balloon dilatation of critical stenosis of the pulmonary valve in neonates.

Authors:  E J Ladusans; S A Qureshi; J M Parsons; S Arab; E J Baker; M Tynan
Journal:  Br Heart J       Date:  1990-06

8.  Major determinants and long-term outcomes of successful balloon dilatation for the pediatric patients with isolated native valvular pulmonary stenosis: a 10-year institutional experience.

Authors:  Meng-Luen Lee; Jui-Wen Peng; Guo-Jhueng Tu; San-Yi Chen; Jyong-You Lee; Shu-Lin Chang
Journal:  Yonsei Med J       Date:  2008-06-30       Impact factor: 2.759

9.  Mechanism of ribosome shutdown by RsfS in Staphylococcus aureus revealed by integrative structural biology approach.

Authors:  Iskander Khusainov; Bulat Fatkhullin; Simone Pellegrino; Aydar Bikmullin; Wen-Ti Liu; Azat Gabdulkhakov; Amr Al Shebel; Alexander Golubev; Denis Zeyer; Natalie Trachtmann; Georg A Sprenger; Shamil Validov; Konstantin Usachev; Gulnara Yusupova; Marat Yusupov
Journal:  Nat Commun       Date:  2020-04-03       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.